CareersFind a DoctorMake an AppointmentDepartmentsDirections & ParkingGiftsContact UsPRINT

	Neurology   From the Chair   Faculty   Grand Rounds   Presentations   Research   Outpatient Clinic   Neurology Sections   Adult Residency   Pediatric Residency   Fellowships   Neurology in the News		WFUBMC Home   >    Neurology   >    Research   >    48 Week Open-Label keppra Extension Title:  A Multi-Center, Open-Label, Long-Term, Follow-Up Study Of The Safety And Efficacy of Levetiracetam In Children With Partial Onset Seizures. Principal Investigator: Maria Sam, M.D. 48 weeks open-label Keppra extension of 1103 and 1009 Inclusion Criteria: 48 week open-label treatment with Keppra Epilepsy  Completed Contact: Nancy Buchheimer 336-716-3961 nbuchhe@wfubmc.edu Sponsor: UCB Completed

[Website Access Agreement] [Privacy Notices] [Copyright Information] [Campus Security Act]
Copyright: Wake Forest University School of Medicine and North Carolina Baptist Hospitals. All rights reserved.
Medical Center Boulevard
Winston-Salem, NC 27157
The information on this Website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified healthcare provider. If you have a medical problem or a health-related question, consult your physician or call Health On-Call at 336-716-2255 or 1-800-446-2255.
Send Feedback	Home	Site Index
	Last Modified: 1/25/2008